Grown Rogue International (GRUSF) Interest Coverage Ratio Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Interest Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -58.34% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -14.91% |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -97.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -97.84% |
| Sep 30, 2025 | -41,580,904.85% |
| Jun 30, 2025 | 346,449,238,728,738.75% |
| Mar 31, 2025 | 157.93% |
| Jan 31, 2023 | -53.17% |
| Jan 31, 2022 | 96.33% |
| Jul 31, 2021 | -103.99% |
| Apr 30, 2021 | 103.80% |
| Jan 31, 2021 | -5,766.87% |
| Oct 31, 2020 | -535.79% |
| Jul 31, 2020 | -149.52% |
| Apr 30, 2020 | 105.46% |
| Jan 31, 2020 | -106.98% |
| Oct 31, 2019 | -105.48% |
| Jul 31, 2019 | 588.65% |
| Apr 30, 2019 | -4,765.93% |
| Jan 31, 2019 | 862.97% |
| May 31, 2018 | 6,584.41% |
| Feb 28, 2018 | -1,113.46% |
| Nov 30, 2017 | -45.76% |